Literature DB >> 12116356

BD Biosciences contributions in CD4 counting and immune status for HIV/AIDS.

Robert A Hoffman1, Vernon C Maino, Diether J Recktenwald, H Kyle Webster.   

Abstract

BD Biosciences is a leader in the use of flow cytometry for determining immune system status and for counting CD4 cells in patients with human immunodeficiency virus (HIV) infection. The company has gained this position through many years of basic research and product development in immunology and cell biology, dye chemistry, immunoassays, instrumentation, and software. Some of the highlights of these developments and their historical perspective are described in this review. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116356     DOI: 10.1002/cyto.10095

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  3 in total

1.  Immunomodulatory effects of icariin in a myocardial infarction mouse model.

Authors:  Xiyalatu Sai; Zhetao Li; Gang Deng; Lu Wang; Wang Xiaowu; Moussa Ide Nasser; Chi Liu; Ping Zhu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana.

Authors:  Hermann Bussmann; C William Wester; Kereng V Masupu; Trevor Peter; Sarah M Gaolekwe; Soyeon Kim; Ann Marie Reich; Sam Ahn; Ying Wu; Ibou Thior; Max Essex; Richard Marlink
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

3.  Performance verification of the new fully automated Aquios flow cytometer PanLeucogate (PLG) platform for CD4-T-lymphocyte enumeration in South Africa.

Authors:  Lindi-Marie Coetzee; Deborah K Glencross
Journal:  PLoS One       Date:  2017-11-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.